This inventor holds 1 USPTO granted patent. Top assignee: Mogam Institute for Biomedical Research. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Eui Cheol Cho: Innovator in Biomedical Research
Introduction
Eui Cheol Cho is a prominent inventor based in Yongin, South Korea. He has made significant contributions to the field of biomedical research, particularly in the development of innovative therapeutic agents for central nervous system diseases.
Latest Patents
Eui Cheol Cho holds a patent for a fusion protein comprising iduronate-2-sulfatase (IDS) and its use. This asymmetric fusion protein combines a fragment of an antibody that binds to the insulin receptor, the IDS enzyme, and an Fc region. The unique feature of this fusion protein is its ability to cross the blood-brain barrier (BBB), allowing for the delivery of the IDS enzyme directly to the brain. This advancement holds promise for treating various diseases caused by ribosome accumulation.
Career Highlights
Eui Cheol Cho is affiliated with the Mogam Institute for Biomedical Research, where he continues to push the boundaries of scientific research. His work focuses on developing innovative solutions to complex medical challenges, particularly in the realm of neurodegenerative diseases.
Collaborations
Eui Cheol Cho collaborates with esteemed colleagues, including Mijung Lee and Ki Joon Cho. Their combined expertise enhances the research efforts at the Mogam Institute, fostering an environment of innovation and discovery.
Conclusion
Eui Cheol Cho's contributions to biomedical research, particularly through his patented fusion protein, exemplify the potential of innovative therapies in addressing critical health issues. His work continues to inspire advancements in the field, paving the way for future breakthroughs.